We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App

Developmental Biologists Locate Source of Liver Stem Cells

By LabMedica International staff writers
Posted on 18 Aug 2015
Print article
Image: Cross-section of the human liver (Photo courtesy of Wikimedia Commons).
Image: Cross-section of the human liver (Photo courtesy of Wikimedia Commons).
Researchers have identified a stem cell line that is responsible for the generation of liver cells (hepatocytes), which are constantly required to maintain the health of the organ.

Working with mice, investigators at Stanford University (Palo Alto, CA, USA) traced the lineage of hepatocytes by determining expression of the Wnt-responsive gene Axin2 (axis inhibition protein 2). The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis.

The investigators reported in the August 5, 2015, online edition of the journal Nature that they had identified a population of proliferating and self-renewing cells adjacent to the central vein in the liver lobule. These pericentral cells expressed the early liver progenitor marker Tbx3 (T-box 3), were diploid, and thereby differed from mature hepatocytes, which are mostly polyploid. The descendants of pericentral cells differentiated into Tbx3-negative, polyploid hepatocytes, and could replace all hepatocytes along the liver lobule during homeostatic renewal. The population of liver stem cells was maintained by Wnt signals provided by endothelial cells in the adjacent central vein.

"We have solved a very old problem," said senior author Dr. Roel Nusse, professor of developmental biology at Stanford University. "We have shown that like other tissues that need to replace lost cells, the liver has stem cells that both proliferate and give rise to mature cells, even in the absence of injury or disease. Differentiated hepatocytes have amplified their chromosomes. That is, the cells have more than the usual two copies of every chromosome. This enables the cells to make more proteins, but it really compromises their ability to divide."

Related Links:

Stanford University

Gold Supplier
Proficiency Assessment Software
CellaVision Proficiency Software
Automated RNA Extraction & PCR Setup
Omnia LH 75 Pro
Silver Supplier
SARS-CoV-2 IgG Antibody Test
Epithod AutoDx SARS-CoV-2 IgG
Silver Supplier
Savvygen SARS-CoV-2 Plus

Print article


Clinical Chem.

view channel
VIASURE HLA Celiac Real Time PCR Detection Kit

CerTest VIASURE HLA Celiac RT PCR Kit Enables Rapid Resolution of HLA Haplotypes Associated with Celiac Disease

CerTest Biotec (Zaragoza, Spain) has developed a simple and ready to use real-time PCR for the detection of the principal alleles of the HLA system and the subsequent determination of the DQ2 and DQ8 antigens... Read more


view channel

First-Of-Its Kind Blood Test to Distinguish between Bacterial and Viral Infections Using Body’s Immune Response Granted FDA Clearance

A first-of-its kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes has been granted clearance by the US Food and Drug Administration (FDA).... Read more


view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more


view channel

Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.